Bollard Group’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-383
| Closed | -$27K | – | 322 |
|
|
2022
Q1 | $27K | Hold |
383
| – | – | ﹤0.01% | 376 |
|
|
2021
Q4 | $29K | Hold |
383
| – | – | ﹤0.01% | 379 |
|
|
2021
Q3 | $22K | Hold |
383
| – | – | ﹤0.01% | 387 |
|
|
2021
Q2 | $17K | Hold |
383
| – | – | ﹤0.01% | 396 |
|
|
2021
Q1 | $19K | Hold |
383
| – | – | ﹤0.01% | 396 |
|
|
2020
Q4 | $16K | Hold |
383
| – | – | ﹤0.01% | 395 |
|
|
2020
Q3 | $18K | Sell |
383
-1,208
| -76% | -$56.8K | ﹤0.01% | 390 |
|
|
2020
Q2 | $80K | Buy |
+1,591
| New | +$80K | ﹤0.01% | 282 |
|